(Q45351788)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Interferon-lambda polymorphisms and hepatitis C virus clearance revisited (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Joachim Lupberger

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

Thomas F Baumert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

17 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

439-441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

Interferon-inducible effector mechanisms in cell-autonomous immunity

28 February 2020

cites work

1 reference

Antiviral strategies in hepatitis C virus infection

21 January 2018

1 reference

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

21 January 2018

1 reference

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response

21 January 2018

1 reference

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

IL28B single nucleotide polymorphisms in the treatment of hepatitis C.

21 January 2018

1 reference

Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C.

21 January 2018

1 reference

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

21 January 2018

1 reference

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

21 January 2018

Innate immunity and HCV.

1 reference

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

Clinical utility of interleukin-28B testing in patients with genotype 1.

21 January 2018

1 reference

Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.26443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23564545%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference